Skip to main content

View full-text article in PMC

. 2012 Feb;23(2):334–342. doi: 10.1681/ASN.2011030287

Table 2.

Effects of hemodialysis and treatment on markers of inflammation

	Time					P Value
	0	30 min	1 h	4 h	6 h	Time	Drug
IL-8 (pg/ml)						0.01	0.002
placebo	40.2±6.0	27.5±4.0^a	28.9±5.1^a	34.1±6.3^a	35.0±5.5
ARB	38.2±5.9	25.8±3.7^a	30.4±6.2^a	30.5±4.9^a	30.8±4.2^a
ACE inhibitor	31.8±3.6	26.4±3.5^a	25.3±4.0^a	26.9±3.0^a	30.1±3.3
MCP-1 (pg/ml)						<0.001	0.51
placebo	415±113	277±65^a	264±59^a	332±104^a	387±87
ARB	364±108	273±61^a	280±56^a	344±79	378±108
ACE inhibitor	353±74	286±48	257±53^a	333±58	370±83

Data are presented as mean ± SEM. MCP-1, monocyte chemoattractant protein-1.

^a

P<0.05 versus baseline.